Response to the response to the letter: "The effect of P2Y12 receptor inhibitors on clinical outcomes in patients with acute coronary syndrome undergoing PCI and receiving abciximab". [PDF]
Cardiol JUmińska JM.
europepmc +1 more source
Knockout of P2Y12 receptor facilitates neuronal envelopment by reactive microglia and accelerates prion disease. [PDF]
J NeuroinflammationMakarava N +7 more
europepmc +1 more source
The Extended Safety and Efficacy of Indobufen in Conjunction With P2Y12 Receptor Inhibitors Among Patients Undergoing Revascularization: A Meta-Analysis and Overview. [PDF]
Cardiovasc TherYi M, Cao Q, Sheng YH, Wu L, Ke X.
europepmc +1 more source
GP IIb/IIIa Receptor Inhibitors in Mechanically Ventilated Patients with Cardiogenic Shock due to Myocardial Infarction in the Era of Potent P2Y12 Receptor Antagonists. [PDF]
J Clin Med, 2022 Kanic V, Kompara G, Suran D.
europepmc +1 more source
Design, Synthesis and Preclinical Evaluation of a Brain-Permeable PET Tracer for P2Y12 Receptor Imaging in the Brain. [PDF]
J Med ChemJoseph E +11 more
europepmc +1 more source
Correction to: Role and recent progress of P2Y12 receptor in cancer development. [PDF]
Purinergic SignalXi Y, Min Z, Liu M, Lin X, Yuan ZH.
europepmc +1 more source
The current status and outcomes of in-hospital P2Y12 receptor inhibitor switching in Korean patients with acute myocardial infarction. [PDF]
Korean J Intern Med, 2022 Park KH +26 more
europepmc +1 more source
Platelet reactivity when switching from cangrelor to oral P2Y12 receptor inhibitors: insights from a real-world registry. [PDF]
EuroInterventionFranchi F, Laudani C.
europepmc +1 more source